European network of bipolar research expert centre (ENBREC): A network to foster research and promote innovative care

International Journal of Bipolar Disorders

Volumn 1, Issue 1, 2013, Pages 1-8

  Henry, Chantal ^a,b,c,d   Andreassen, Ole A ^e   Barbato, Angelo ^f   Demotes Mainard, Jacques ^g   Goodwin, Guy ^h   Leboyer, Marion ^a,b,c,d   Vieta, Eduard ⁱ   Nolen, Willem A ^j   Kessing, Lars Vedel ^k   Scott, Jan ^l   Bauer, Michael ^m   Etain B ⁿ   Remond C ⁿ   Jamain, S ⁿ   Bellivier, F ⁿ   Morken, G ⁿ   D'Avanzo, B ⁿ   Parabiaghi, A ⁿ   Rapisarda, F ⁿ   Vallarino, M ⁿ   Bourne, C ⁿ   Geddes, J R ⁿ   Pfennig, A ⁿ   Ritter, P ⁿ   van der Wee, N ⁿ   Boyer, Patrice ⁿ   more..

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b INSERM U955   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d FONDATION FONDAMENTAL   (France)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^g INSERM   (France)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ UNIVERSITY OF BARCELONA   (Spain)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

^l NEWCASTLE UNIVERSITY   (United Kingdom)

^m UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

ⁿ European Commission   (United Kingdom)

more..

Author keywords

Bipolar disorder; Clinical practice; Research networks; Standards of care

Indexed keywords

BEHAVIORAL RESEARCH; BIPOLAR DISORDER; CLINICAL ASSESSMENT; COGNITION; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; LIFE EXPECTANCY; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; RATING SCALE; REVIEW; STRUCTURED INTERVIEW;

EID: 84880108775     PISSN: None     EISSN: 21947511     Source Type: Journal    
DOI: 10.1186/2194-7511-1-2     Document Type: Review

References (46)

1. Altman EG, Hedeker D, Peterson JL, Davis JM. The Altman Self-Rating Mania Scale. Biological Psychiatry. 1997; 42(10):948-955. doi:10.1016/S0006-3223(96)00548-3.
2. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. American Psychiatric Association: Text Revision. Washington DC; 2000.
3. Baca-Garcia E, Perez-Rodriguez MM, Basurte-Villamor I, Lopez-Castroman J, Fernandez del Moral AL, Jimenez-Arriero MA, Gronzalez de Rivera JL, Saiz-Ruiz J, Leiva-Murillo JM, de Prado-Cumplido M, Santiago-Mozos R, Artes-Rodriguez A, Oquendo MA, de Leon J. Diagnostic stability and evolution of bipolar disorder in clinical practice: a prospective cohort study. Acta Psychiatrica Scandinavica. 2007; 115(6):473-480. doi:10.1111/j.1600-0447.2006.00984.x.
4. Bauer MS, Biswas K, Kilbourne AM. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care. The American Journal of Psychiatry. 2009; 166(11):1244-1250. doi:10.1176/appi.ajp.2009.09030342.
5. Bostwick JM, Pankratz VS. Affective disorders and suicide risk: a reexamination. The American Journal of Psychiatry. 2000; 157(12):1925-1932. doi:10.1176/appi. ajp.157.12.1925.
6. Chang CK, Hayes RD, Perera G, Broadbent MT, Fernandes AC, Lee WE, Hotopf M, Stewart R. Life expectancy at birth for people with serious mental illness and other major disorders from a secondary mental health care case register in London. PLoS One. 2011; 6(5):e19590. doi:10.1371/journal.pone.0019590.
7. Colom F, Vieta E, Daban C, Pacchiarotti I, Sanchez-Moreno J. Clinical and therapeutic implications of predominant polarity in bipolar disorder. J Affect Disord. 2006; 93(1-3):13-17. doi:10.1016/j.jad.2006.01.032.
8. Dutta R, Boydell J, Kennedy N, Van OS, Fearon P, Murray RM. Suicide and other causes of mortality in bipolar disorder: a longitudinal study. Psychological Medicine. 2007; 37(6):839-847. doi:10.1017/S0033291707000347.
9. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured clinical interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
10. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci USA. 2000; 97(20):11050-11055. doi:10.1073/pnas.200033797.
11. Forcada I, Papachristou E, Mur M, Christodoulou T, Jogia J, Reichenberg A, Vieta E, Frangou S. The impact of general intellectual ability and white matter volume on the functional outcome of patients with Bipolar Disorder and their relatives. J Affect Disord. 2011; 130(3):413-420. doi:10.1016/j.jad.2010.10.048.
12. Frye MA, Ketter TA, Leverich GS, Huggins T, Lantz C, Denicoff KD, Post RM. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. The Journal of Clinical Psychiatry. 2000; 61(1):9-15. doi:10.4088/JCP.v61n0104.
13. Gitlin MJ, Swendsen J, Heller TL, Hammen C. Relapse and impairment in bipolar disorder. The American Journal of Psychiatry. 1995; 152(11):1635-1640.
14. Goodwin GM, Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009; 23(4):346-388.
15. Goodwin GM, Martinez-Aran A, Glahn DC, Vieta E. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? An ECNP expert meeting report. Eur Neuropsychopharmacol. 2008; 18(11):787-793. doi:10.1016/j.euroneuro.2008.07.005.
16. Henry C, Etain B, Mathieu F, Raust A, Vibert JF, Scott J, Leboyer M. A French network of bipolar expert centres: a model to close the gap between evidence-based medicine and routine practice. J Affect Disord. 2011; 131 (1-3):358-363. doi:10.1016/j.jad.2010.11.013.
17. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. The Journal of Clinical Psychiatry. 2003; 64(2):161-174. doi:10.4088/ JCP.v64n0209.
18. Kessing LV, Hansen HV, Hvenegaard A, et al. Treatment in a specialised outpatient mood disorder clinic v. standard out-patient treatment in the early course of bipolar disorder: randomised clinical trial. Br J Psychiatry. 2013; 202:212-219.
19. Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry. 2010; 71(12):1689-1695. doi:10.4088/JCP.10m06347yel.
20. Lopez AD, Murray CC. The global burden of disease, 1990-2020. Nat Med. 1998; 4(11):1241-1243. doi:10.1038/3218.
21. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992; 31(Pt 3):301-306. doi:10.1111/j.2044-8260.1992.tb00997.x.
22. Martinez-Aran A, Scott J, Colom F, Torrent C, Tabares-Seisdedos R, Daban C, Leboyer M, Henry C, Goodwin GM, Gonzalez-Pinto A, Cruz N, Sanchez-Moreno J, Vieta E. Treatment nonadherence and neurocognitive impairment in bipolar disorder. J Clin Psychiatry. 2009; 70(7):1017-1023. doi:10.4088/JCP.08m04408.
23. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Archives of General Psychiatry. 2007; 64(5):543-552. doi:10.1001/archpsyc.64.5.543.
24. Miklowitz DJ, Scott J. Psychosocial treatments for bipolar disorder: cost-effectiveness, mediating mechanisms, and future directions. Bipolar Disorders. 2009; 11(Suppl 2):110-122. doi:10.1111/j.1399-5618.2009.00715.x.
25. Montgomery SA, Åsberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979; 134:382-389. doi:10.1192/bjp.134.4.382.
26. Müller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet. 2002; 359(9302):241-247. doi:10.1016/S0140-6736(02)07450-0.
27. Nivoli AM, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, Fountoulakis KN, Vieta E. New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord. 2011a; 129(1-3):14-26. doi:10.1016/j.jad.2010.05.018.
28. Nivoli AM, Murru A, Goikolea JM, Crespo JM, Montes JM, González-Pinto A, García-Portilla P, Bobes J, Sáiz-Ruiz J, Vieta E. New treatment guidelines for acute bipolar mania: a critical review. J Affect Disord. 2011b; 140(2):125-141. doi:10.1016/j.jad.2011.10.015.
29. Pontin E, Peters S, Lobban F, Rogers A, Morriss RK. Enhanced relapse prevention for bipolar disorder: a qualitative investigation of value perceived for service users and care coordinators. Implement Sci. 2009; 4:4. doi:10.1186/ 1748-5908-4-4.
30. Rimol LM, Hartberg CB, Nesvag R, Fennema-Notestine C, Hagler DJ Jr, Pung CJ, Jennings RG, Haukvik UK, Lange E, Nakstad PH, Melle I, Andreassen OA, Dale AM, Agartz I. Cortical thickness and subcortical volumes in schizophrenia and bipolar disorder. Biological Psychiatry. 2010; 68(1):41-50. doi:10.1016/j. biopsych.2010.03.036.
31. Rosa AR, Sanchez-Moreno J, Martinez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, Kapczinski F, Vieta E. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007; 3:5. doi:10.1186/ 1745-0179-3-5.
32. Rosa AR, Reinares M, Amann B, Popovic D, Franco C, Comes M, Torrent C, Bonnín CM, Solé B, Valentí M, Salamero M, Kapczinski F, Vieta E. Six-month functional outcome of a bipolar disorder cohort in the context of a specialized-care program. Bipolar Disord. 2011; 13(7-8):679-686. doi:10.1111/ j.1399-5618.2011.00964.x.
33. Rush AJ, Trivedi MH, Ibrahim HM, Carmody TJ, Arnow B, Klein DN, Markowitz JC, Ninan PT, Kornstein S, Manber R, Thase ME, Kocsis JH, Keller MB. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biological Psychiatry. 2003; 54(5):573-583. doi:10.1016/S0006-3223(02)01866-8.
34. Scott J. Bipolar disorders: from early intervention to personalized treatment. Early Intervention in Psychiatry. 2011; 5:89-90. doi:10.1111/j.1751-7893.2011.00274.x.
35. Scott J, Leboyer M. Consequences of mis-diagnosis of bipolar disorder. L'encephale. 2012:. in press.
36. Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry. 2006; 188:313-320. doi:10.1192/bjp.188.4.313.
37. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. The Journal of Clinical Psychiatry. 1998; 59(Suppl 20):22-33. quiz 34-57.
38. Vieta E, Pacchiarotti I, Valenti M, Berk L, Scott J, Colom F. A critical update on psychological interventions for bipolar disorders. Curr Psychiatry Rep. 2009; 11(6):494-502. doi:10.1007/s11920-009-0075-0.
39. Vieta E, Phillips ML. Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull. 2007; 33(4):886-892. doi:10.1093/schbul/sbm057.
40. Vieta Pascual E, Torrent Font C, Martínez-Arán A, Colom Victoriano F, Reinares Gabnepen M, Benabarre Hernández A, Comes Forastero M, Goikolea Alberdi JM. Escala sencilla de evaluación del curso del trastorno bipolar: CGI-BP -M. Actas Esp Psiquiat. 2002; 30(5):301-304.
41. Vieta E, Blasco-Colmenares E, Figueira ML, Langosch JM, Moreno-Manzanaro M, Medina E, WAVE-bd Study Group. Clinical management and burden of bipolar disorder: a multinational longitudinal study (WAVE-bd study). BMC Psychiatry. 2011; 11:58.
42. Vieta E. Bipolar units and programmes: are they really needed? World Psychiatry. 2011; 10(2):152.
43. Vieta E, Cruz N. Head to head comparisons as an alternative to placebo-controlled trials. Eur Neuropsychopharmacol. 2012; 22(11):800-803. doi:10.1016/ j.euroneuro.2011.11.011.
44. Olesen J, Gustavsson A, Svensson M, Wittchen HU, Jönsson B, CDBE2010 study group; European Brain Council. The economic cost of brain disorders in Europe. Eur J Neurol. 2012; 19(1):155-162. doi:10.1111/j.1468-1331.2011.03590.x.
45. Wolfsperger M, Greil W, Rossler W, Grohmann R. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004. J Affect Disord. 2007; 99(1-3):9-17. doi:10.1016/j.jad.2006.08.017.
46. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133:429-435. doi:10.1192/bjp.133.5.429.